Skip to content
investormap

Pureos Bioventures

BB Pureos Bioventures · Venture capital

UncertainLast verified 10 Nov 2026

Pureos Bioventures is a Swiss venture capital firm investing in private innovative drug development companies, focusing on next-generation biological drugs and novel therapeutics for severe diseases.

0 deals in the last 24 months, latest 13 Apr 2023. Taken from its own website.

Key facts

Sectors
Biotech & pharma
Eligible countries
Not stated
Provider based in
Switzerland
Timing
Rolling applications
Focus
innovative drug development companies; biological drugs and drug formats; therapeutics for severe diseases
How to apply
Apply route unknown

Recent deals

No deals in our data for the last 24 months.

Evidence

Short excerpts from the sources, in their original language, that back the facts above.

  • KindPureos Bioventures invests venture capital in private innovative drug development companieshttps://www.pureosbio.com/
  • SectorsPureos Bioventures invests venture capital in private innovative drug development companies, with an emphasis on the next generation of biological drugs and…https://www.pureosbio.com/

Status history

  • 10 Nov 2026: Rolling → Uncertain (freshness: investor activity)
  • 6 Nov 2026: Rolling (first extraction)

Is something out of date?

Suggest an editTakes 10 seconds
What is wrong?

Please do not include names, email addresses or phone numbers of people.

Something else wrong? Report an error.

Work at BB Pureos Bioventures? Claim this profile to confirm what you invest in.